Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
About this item
Full title
Author / Creator
Publisher
Atlanta: Wiley Subscription Services, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: Wiley Subscription Services, Inc
Subjects
More information
Scope and Contents
Contents
Poly(ADP-ribose) polymerase (PARP) is an attractive antitumor target because of its vital role in DNA repair. The homologous recombination (HR) DNA repair pathway is critical for the repair of DNA double-strand breaks and HR deficiency leads to a dependency on error-prone DNA repair mechanisms, with consequent genomic instability and oncogenesis. T...
Alternative Titles
Full title
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_851268774
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_851268774
Other Identifiers
ISSN
0007-9235
E-ISSN
1542-4863
DOI
10.3322/caac.20095